BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10217205)

  • 1. Salt bridge residues between I-Ak dimer of dimers alpha-chains modulate antigen presentation.
    Yadati S; Nydam T; Demian D; Wade TK; Gabriel JL; Barisas BG; Wade WF
    Immunol Lett; 1999 Mar; 67(1):47-55. PubMed ID: 10217205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation.
    Nydam T; Wade TK; Yadati S; Gabriel JL; Barisas BG; Wade WF
    Int Immunol; 1998 Aug; 10(8):1237-49. PubMed ID: 9723711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of two DR alpha residues involved in dimers of HLA-DR molecules.
    Goodman S; Sawada T; Barbosa JA; Cole B; Pergolizzi R; Silver J; Mellins E; Chang MD
    J Immunol; 1995 Aug; 155(3):1210-7. PubMed ID: 7636189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune function of MHC class II molecules mutated in the putative superdimer interface.
    Hayball JD; Lake RA
    Mol Cell Biochem; 2005 May; 273(1-2):1-9. PubMed ID: 16013435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules.
    Wei BY; Buerstedde JM; Bell M; Chase C; Nilson A; Browne A; Pease L; McKean DJ
    J Immunol; 1991 Apr; 146(7):2358-66. PubMed ID: 1706396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
    Stebbins CC; Loss GE; Elias CG; Chervonsky A; Sant AJ
    J Exp Med; 1995 Jan; 181(1):223-34. PubMed ID: 7807005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics of point mutated I-A(k) molecules expressed on lymphocytes.
    Munnelly HM; Brady CJ; Hagen GM; Horvat RD; Wade WF; Roess DA; Barisas BG
    Immunol Lett; 2001 Jul; 77(3):187-96. PubMed ID: 11410253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of MHC class II: a role for dimer of dimers.
    Schafer PH; Pierce SK; Jardetzky TS
    Semin Immunol; 1995 Dec; 7(6):389-98. PubMed ID: 8775464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A beta polymorphic residues responsible for class II molecule recognition by alloreactive T cells.
    Buerstedde JM; Nilson AE; Chase CG; Bell MP; Beck BN; Pease LR; McKean DJ
    J Exp Med; 1989 May; 169(5):1645-54. PubMed ID: 2469762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the antigen binding region of an MHC class II molecule.
    Rosloniec EF; Beard KS; Freed JH
    Mol Immunol; 1993 Apr; 30(5):491-501. PubMed ID: 7681933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation.
    Laufer TM; Smiley ST; Ranger A; Clements VK; Ostrand-Rosenberg S; Glimcher LH
    J Immunol; 1997 Dec; 159(12):5914-20. PubMed ID: 9550388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
    Barber LD; Lechler RI
    J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional sites on the A alpha-chain. Polymorphic residues involved in antigen presentation to insulin-specific, Ab alpha:Ak beta-restricted T cells.
    Reske-Kunz AB; Landais D; Peccoud J; Benoist C; Mathis D
    J Immunol; 1989 Sep; 143(5):1472-81. PubMed ID: 2474599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.
    Riberdy JM; Cresswell P
    J Immunol; 1992 Apr; 148(8):2586-90. PubMed ID: 1373173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants.
    Pious D; Dixon L; Levine F; Cotner T; Johnson R
    J Exp Med; 1985 Oct; 162(4):1193-207. PubMed ID: 2413154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition.
    Tate KM; Lee C; Edelman S; Carswell-Crumpton C; Liblau R; Jones PP
    Int Immunol; 1995 May; 7(5):747-61. PubMed ID: 7547702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme.
    Fremont DH; Monnaie D; Nelson CA; Hendrickson WA; Unanue ER
    Immunity; 1998 Mar; 8(3):305-17. PubMed ID: 9529148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.